Nasdaq

Cybin Initiates PARADIGM: A Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder and Reports Second Quarter ...

- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - EXTEND: a Phase III Open Label Extension Study ...
FOX31 Denver

NAIC's Paradigm Changers Internship Program is Building a Pathway for Women to Pursue Careers in Alternatives

WASHINGTON, May 2, 2024 /PRNewswire/ -- The National Association of Investment Companies (NAIC) is pleased to announce the 2024 cohort of Paradigm Changers interns. Launched in 2021, NAIC's Paradigm ...
WGHP

MPS Clinical Program Update and Paradigm to Present at the International Conference on Lysosomal Diseases

NEW YORK, Aug. 12, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a late-stage drug development company, is pleased to announce that it is scheduled to ...
The Hollywood Reporter

Paradigm, Film2Future Pact for Youth Filmmaking Program

Paradigm and Film2Future have inked a two-year collaborative agreement that will see the talent agency become the exclusive partner of the non-profit that promotes pathways into the entertainment ...
Kaleido Scope

Prospective Students

The PARAdiGM program focuses on undergraduates from diverse and underrepresented minority backgrounds, and offers the opportunity to participate in the program for two summers. In addition to working ...